Antifibrotic effects of suramin in injured skeletal muscle after laceration

Journal of Applied Physiology

Volumn 95, Issue 2, 2003, Pages 771-780

  Chan, Yi Sheng ^a,b,d   Li, Yong ^a,b   Foster, William ^a   Horaguchi, Takashi ^a,b   Somogyi, George ^b   Fu, Freddie H ^b   Huard, Johnny ^a,b,c  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Fibrosis; Muscle injury; Muscle regeneration; Suramin; Transforming growth factor 1

Indexed keywords

ALPHA ACTIN; ANTIFIBROTIC AGENT; ANTIMITOTIC AGENT; SURAMIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CONVALESCENCE; FIBROBLAST; GASTROCNEMIUS MUSCLE; HEALING; LACERATION; MOUSE; MUSCLE INJURY; MUSCLE REGENERATION; MYOFIBROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

EID: 0042629681     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.00915.2002     Document Type: Article

References (66)

1. Alameddine HS, Dehaupas M, and Fardeau M. Regeneration of skeletal muscle fibers from autologous satellite cells multiplied in vitro: an experimental model for testing cultured cell myogenicity. Muscle Nerve 12: 544-555, 1989.
2. Anderson JE, Liu L, and Kardami E. Distinctive patterns of basic fibroblast growth factor (bFGF) distribution in degenerative and regenerating areas of dystrophic (mdx) striated muscle. Dev Biol 147: 96-109, 1991.
3. Aronen JG and Chronister RO. Quadriceps contusion: hastening the return to play. Phys Sportsmed 20: 130-136, 1992.
4. Barbero A, Benelli R, Minghelli S, Tosetti F, Dorcoratto A, Ponzetta C, Wernig A, Cullen M, Albini A, and Noonan D. Growth factor supplemented matrigel improves ectopic skeletal muscle formation - a cell therapy approach. J Cell Physiol 186: 183-192, 2001.
5. 1 and fibrosis in congenital muscular dystrophy. Neuromuscul Disord 9: 28-33, 1999.
6. Bernasconi P, Torchiana E, Confalonieri P, Brugnoni R, Barresi R, Mora M, Cornelio F, Morandi L, and Mantegazza R. Expression of transforming growth factor-β in dystrophic patient muscles correlates with fibrosis: pathogenetic role of a fibrogenic cytokine. J Clin Invest 96: 1137-1144, 1995.
7. Bischoff R. The satellite cell and muscle regeneration. In: Myology (2nd ed.), edited by Eagle AG and Franzini-Armstrong C. New York: McGraw-Hill, 1994, p. 97-118.
8. Bornemann A and Schmalbruch H. Desmin and vimentin in regenerating muscles. Muscle Nerve 15: 14-20, 1992.
9. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
10. Brocks L, Jap PHK, Ramaekers FCC, and Stadhouders AM. Vimentin and desmin expression in degenerating and regenerating dystrophic murine muscles. Virchows Arch B Cell Pathol Incl Mol Pathol 61: 89-96, 1991.
11. Caplan A, Carlson B, and Faulkner J. Injury and repair of the musculoskeletal soft tissue. In: Skeletal Muscle, edited by Woo SLY and Buckwalter JA. Park Ridge, IL: American Academy of Orthopaedic Surgeons, 1988, p. 213-291.
12. Carlson BM and Faulkner JA. The regeneration of skeletal muscle fibers following injury: a review. Med Sci Sports Exerc 15: 187-196, 1983.
13. Chamberlain J, Shah M, and Ferguson MW. The effect of suramin on healing adult rodent dermal wounds. J Anat 186: 87-96, 1995.
14. Chambers RL and McDermott JC. Molecular basis of skeletal muscle regeneration. Can J Appl Physiol 21: 155-184, 1996.
15. 1 in polymyositis and dermatomyositis correlates with fibrosis but not with mononuclear cell infiltrate. J Neuropathol Exp Neurol 56: 479-484, 1997.
16. Crisco JJ, Jokl P, Heinen GT, Connell M, and Panjabi M. A muscle contusion injury model: biomechanics, physiology, and histology. Am J Sports Med 22: 702-710, 1994.
17. Engert JC, Berlund EB, and Rosenthal N. Proliferation precedes differentiation in IGF-1 stimulated myogenesis [letter]. J Cell Biol 125: 431-440, 1996.
18. Florini JR, Ewton DZ, and Coolican SA. Growth hormone and the insulin-like growth factor system in myogenesis. Endocr Rev 17: 481-517, 1996.
19. Florini JR and Magri KA. Effect of growth factors on myogenic differentiation. Am J Physiol Cell Physiol 256: C701-C711, 1989.
20. Foster W, Li Y, Usas A, Somogyi G, and Huard J. Gamma interferon as an antifibrosis agent in skeletal muscle. J Orthop Res. In press.
21. Fukushima K, Badlani N, Usas A, Riano F, Fu F, and Huard J. The use of antifibrosis agent to improve muscle recovery after laceration. Am J Sports Med 29: 394-402, 2001.
22. Garrett WE Jr. Muscle strain injuries: clinical and basic aspects. Med Sci Sports Exerc 22: 436-443, 1990.
23. Garrett WE Jr, Seaber AV, Boswick J, Urbaniak J, and Goldner J. Recovery of skeletal muscle after laceration and repair. J Hand Surg [Am] 9: 683-692, 1984.
24. Grounds MD. Towards understanding skeletal muscle regeneration. Pathol Res Pract 187: 1-22, 1991.
25. Hannafin JA, Pedowitz RA, and Hidaka C. Pathophysiology and healing of musculoskeletal tissues. In: Orthopaedic Knowledge Update, edited by Griffin LY. Rosemont, IL: American Academy of Orthopaedic Surgeons, 1994, p. 17-33.
26. Hawking F. Suramin: with special reference to onchocerciasis. Pharmacol Chemother 106: 216-221, 1987.
27. Holbrook TL, Grazier K, Kelsey JL, and Stauffer RN. The Frequency, Occurrence, Impact and Cost of Selected Musculoskeletal Conditions in the United States. Park Ridge, IL: American Academy of Orthopedic Surgeons, 1984.
28. Huard J, Li Y, and Fu F. Muscle injury and repair: current trends in research. J Bone Joint Surg Am 84: 822-832, 2002.
29. Hughes CIV, Hasselman CT, Best TM, Martinez S, and Garrett W. Incomplete, intrasubstance strain injuries of the rectus femoris muscle. Am J Sports Med 23: 500-506, 1995.
30. Hurme T and Kalimo H. Activation of myogenic precursor cells after muscle injury. Med Sci Sports Exerc 24: 197-205, 1992.
31. Jackson DW and Feagin JA. Quadriceps contusions in young athletes: relation of severity of injury to treatment and prognosis. J Bone Joint Surg Am 55: 95-105, 1973.
32. Jarvinen MJ and Lehto MU. The effects of early mobilisation and immobilisation on the healing process following muscle injuries. Sports Med 15: 78-89, 1993.
33. Jarvinen TA, Kaariainen M, Jarvinen M, and Kalimo H. Muscle strain injuries. Curr Opin Rheumatol 12: 155-161, 2000.
34. Jennische E. Sequential immunohistochemical expression of IGF-1 and the transferrin receptor in regenerating rat muscle in vivo. Acta Endocrinol 121: 733-738, 1989.
35. Jennische E and Hansson HA. Regenerating skeletal muscle cells express insulin-like growth factor 1. Acta Physiol Scand 130:327-332, 1987.
36. Johnson SE and Allen RE. Activation of skeletal muscle satellite cells and the role of fibroblast growth factor receptors. Exp Cell Res 219: 449-453, 1995.
37. Kalimo H, Rantanen J, and Jarvinen M. Soft tissue injuries in sport. Balliere Clin Orthop 2: 1-24, 1997.
38. Kasemkijwattana C, Menetrey J, Bosch P, Somogyi G, Moreland M, Fu F, Buranapanitkit B, Watkins S, and Huard J. Use of growth factors to improve muscle healing after strain injury. Clin Orthop 370: 272-285, 1999.
39. Kasemkijwattana C, Menetrey J, Day CS, Bosch P, Buranapanitkit B, Moreland M, Fu F, and Huard J. Biologic intervention in muscle healing and regeneration. Sports Med Arthrosc Rev 6: 95-102, 1998.
40. Kasemkijwattana C, Menetrey J, Somogyl G, Moreland M, Fu F, Buranapanitkit B, Watkins S, and Huard J. Development of approaches to improve the healing following muscle contusion. Cell Transplant 7: 585-598, 1998.
41. 1 or insulin-like growth factor-1. J Neuroimmunol 57: 85-91, 1995.
42. Lehto M, Jarvinen M, and Nelimarkka O. Scar formation after skeletal muscle injury: a histological and autoradiographical study in rats. Arch Orthop Trauma Surg 104: 366-370, 1986.
43. Levine A, Gill P, Cohen J, Hawkins J, Formenti S, Aguilar S, Meyer P, Krailo M, Parker J, and Rasheed S. Suramin antiviral therapy in the acquired immunodeficiency syndrome. Ann Intern Med 105: 32-37, 1986.
44. Li Y, Cummins J, and Huard J. Muscle injury and repair. Curr Opin Orthop 12: 409-415, 2001.
45. Li Y, Foster W, Badlani N, Sato K, Chan Y, Payne T, and Huard J. TGF-beta1 promotes differentiation of muscle cells toward fibrotic cells (Abstract). Trans 48th Ann Meeting Orthopaed Res Soc 27: O655, 2002.
46. 2-microglobulin expression in Hela cells induced with r-INF. Transplant Proc 31: 2143-2145, 1999.
47. Li Y and Huard J. Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am J Pathol 161: 895-907, 2002.
48. Menetrey J, Kasemkijwattana C, Day CS, Bosch P, Vogt M, Fu F, Moreland M, and Huard J. Growth factors improve muscle healing in vivo. J Bone Joint Surg Br 82: 131-137, 2000.
49. Menetrey J, Kasemkijwattana C, Fu FH, Moreland M, and Huard J. Suturing versus immobilization of a muscle laceration. A morphological and functional study in a mouse model. Am J Sports Med 27: 222-229, 1999.
50. Mietz H, Chevez-Barrios P, Feldman RM, and Lieberman M. Suramin inhibits wound healing following filtering procedures for glaucoma. Br J Ophthalmol 82: 816-820, 1998.
51. Mietz H, Chevez-Barrios P, Lieberman MW, Wendt M, Gross R, and Basinger S. Decorin and suramin inhibit ocular fibroblast collagen production. Graefes Arch Clin Exp Ophthalmol 235: 399-403, 1997.
52. Moller-Pederson T, Cavanag HD, Petroll WM, and Jester J. Neutralizing antibody to TGF-β moderates stromal fibrosis but not regression of photoablative effect following PRK. Curr Eye Res 17: 736-747, 1998.
53. Nikolaou PK, Macdonald BL, Glisson RR, Seaber AV, and Garrett WE Jr. Biomechanical and histological evaluation of muscle after controlled strain injury. Am J Sports Med 15: 9-14, 1987.
54. Quinn LS and Haugk KL. Overexpression of the type-1 insulin-like growth factor receptor increases ligand-dependent proliferation and differentiation in bovine skeletal myogenic culture. J Cell Physiol 168: 34-41, 1996.
55. Ryan JB, Wheeler JH, Hopkinson WJ, Arciero R, and Kolakowski K. Quadriceps contusions, West Point Update. Am J Sports Med 19: 299-304, 1991.
56. Schrell UMH, Gauer S, Kiesewetter F, Bickel A, Hren J, Adams E, and Fahlbusch R. Inhibition of proliferation of human cerebral meningioma cells by suramin: effects on cell growth, cell cycle phase, extracellular growth factors, and PDGF-BB autocrine growth loop. J Neurosurg 82: 600-607, 1995.
57. Schultz E. Satellite cell behavior during skeletal muscle growth and regeneration. Med Sci Sports Exerc 21: S181-S186, 1989.
58. Schultz E, Jaryszak DL, and Valliere CR. Response of satellite cells to focal skeletal muscle injury. Muscle Nerve 8: 217-222, 1985.
59. Serini G and Gabbiani G. Mechanism of myofibroblast activity and phenotypic modulation. Exp Cell Res 250: 273-283, 1999.
60. Stein CA. Suramin, a novel antineoplastic agent with multiple potential mechanisms of action. Cancer Res 53: 2239-2248, 1993.
61. Sullivan KM, Lorenz HP, Meuli M, Meuli M, Lin R, and Adzick N. A model of scarless human fetal wound repair is deficient in transforming growth factor β. J Pediatr Surg 30: 198-203, 1995.
62. Taylor DC, Dalton JD Jr, Seaber AV, and Garrett WE. Experimental muscle strain injury: early functional and structural deficits, and the increased risk for reinjury. Am J Sports Med 21: 190-194, 1993.
63. Thomas DW, O'Neill ID, Harding KG, and Shephard J. Cutaneous wound healing: a current perspective. J Oral Maxillofac Surg 53: 2239-2248, 1995.
64. 2-macroglobulin. J Hepatol 26: 1220-1228, 1997.
65. 1 modulates myofibroblastic phenotype of rat palatal fibroblasts in vitro. Exp Cell Res 231: 328-336, 1997.
66. Zumkeller W and Schofield PN. Growth factors, cytokines and soluble forms of receptor molecules in cancer patients. Anticancer Res 15: 344-348, 1995.